ClinicalTrials.Veeva

Find clinical trials for Adenocarcinoma in Birmingham, AL

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Carcinoma
Cancer
Pancreatic Cancer
Stomach Cancer
Colorectal Cancer
Prostatic Cancer
Esophageal Cancer

Adenocarcinoma trials near Birmingham, AL, USA:

Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel (PANOVA-3)

for front line treatment of locally-advanced pancreatic adenocarcinoma.The device is an experimental, portable, battery operated device for ...

Active, not recruiting
Pancreas Adenocarcinoma
Drug: Gemcitabine
Drug: nab paclitaxel

Phase 3

NovoCure
NovoCure

Birmingham, Alabama, United States and 197 other locations

This study is being done to see if tucatinib with trastuzumab, ramucirumab and paclitaxel works better than ramucirumab and paclitaxel to treat HER2-...

Active, not recruiting
Esophageal Adenocarcinoma
Gastroesophageal Junction Adenocarcinoma
Drug: paclitaxel
Drug: trastuzumab

Phase 2, Phase 3

Seagen
Seagen

Birmingham, Alabama, United States and 47 other locations

Barrett's Esophagus (BE), with or without dysplasia, and esophageal adenocarcinoma (EAC) as compared to Esophagogastroduodenoscopy (EGD) plu...

Enrolling
Esophageal Adenocarcinoma
Barretts Esophagus With Dysplasia
Diagnostic Test: Esophagogastroduodenoscopy
Device: EsoGuard (lab assay)
Lucid Diagnostics

Birmingham, Alabama, United States and 37 other locations

activity of ProAgio combined with gemcitabine and nab paclitaxel (G-nP) in previously untreated subjects with metastatic pancreatic ductal adenocarcinoma...

Enrolling
Pancreatic Ductal Carcinoma
Drug: ProAgio Dose Levels (DL) 1,2,3,4
Drug: Gemcitabine, nab paclitaxel

Phase 1

ProDa BioTech

Birmingham, Alabama, United States

The purpose of this study is to look at the efficacy and safety of Irinotecan liposome injection in combination with other approved drugs used for ca...

Active, not recruiting
Metastatic Adenocarcinoma of the Pancreas
Drug: Leucovorin
Drug: Gemcitabine

Phase 3

Ipsen
Ipsen

Birmingham, Alabama, United States and 199 other locations

To evaluate the safety and tolerability of escalating doses of ERAS-007 in combination with other cancer therapies in study participants with advance...

Active, not recruiting
Metastatic Pancreatic Ductal Adenocarcinoma
Metastatic Colorectal Cancer
Drug: Cetuximab
Drug: ERAS-007

Phase 1, Phase 2

Erasca

Birmingham, Alabama, United States and 13 other locations

KRAS G12C-mutant non-small cell lung cancer (NSCLC), pancreatic duct adenocarcinoma (PDAC), biliary tract cancer (BTC), or colorectal cancer...

Active, not recruiting
Advanced Solid Tumors
Drug: Adagrasib
Drug: BMS-986466

Phase 1, Phase 2

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Birmingham, Alabama, United States and 31 other locations

The purpose of this study is to assess the safety, tolerability and preliminary efficacy of CC-94676 in men with progressive metastatic castration re...

Enrolling
Prostatic Neoplasms
Drug: CC-94676
Drug: CC1083610

Phase 1

Celgene
Celgene

Birmingham, Alabama, United States and 24 other locations

This is a first-in-human, 3-part study to investigate the safety, tolerability, and effectiveness of ZW25 (zanidatamab) by itself and combined with s...

Active, not recruiting
HER2-expressing Cancers
Drug: Capecitabine
Drug: ZW25 (Zanidatamab)

Phase 1

Jazz Pharmaceuticals
Jazz Pharmaceuticals

Birmingham, Alabama, United States and 16 other locations

This is a first-in-human Phase 1 clinical trial designed to investigate the safety, tolerability, pharmacokinetics, and biodistribution of [225Ac]-FP...

Enrolling
Pancreatic Ductal Adenocarcinoma (PDAC)
NTSR1 Expressing Solid Tumours
Drug: [225]-FPI-2059
Drug: [111In]-FPI-2058

Phase 1

Fusion Pharmaceuticals

Birmingham, Alabama, United States and 7 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems